Vipul Life Science Profile
Key Indicators
- Authorised Capital ₹ 6.25 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.36 Cr
as on 24-10-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 20.20 Cr
as on 24-10-2024
- Revenue -28.90%
(FY 2023)
- Profit -9.48%
(FY 2023)
- Ebitda 18.48%
(FY 2023)
- Net Worth 10.70%
(FY 2023)
- Total Assets -20.12%
(FY 2023)
About Vipul Life Science
The Corporate was formerly known as Vipul Dyes And Solvents P Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.25 Cr and a paid-up capital of Rs 1.36 Cr.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹20.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vipul Gondhiya, Sunilkumar Sheth, Vipul Sheth, and One other member serve as directors at the Company.
- CIN/LLPIN
U24114MH2003PLC084942
- Company No.
084942
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2003
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vipul Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunilkumar Sheth  | Managing Director | 30-Sep-2003 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipul Gondhiya | Director | 17-Dec-2022 | Current |
| Vipul Sheth | Whole-Time Director | 30-Sep-2003 | Current |
| Paresh Sheth | Director | 17-Dec-2022 | Current |
Financial Performance of Vipul Life Science.
Vipul Life Science Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.9% decrease. The company also saw a slight decrease in profitability, with a 9.48% decrease in profit. The company's net worth Soared by an impressive increase of 10.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vipul Life Science?
In 2023, Vipul Life Science had a promoter holding of 97.36% and a public holding of 2.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meru Advisory Services LlpActive 10 years 7 monthsSunilkumar Sheth and Vipul Sheth are mutual person
- Dew Healthcare Research LlpActive 8 years 9 months
Sunilkumar Sheth and Vipul Sheth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 12 Dec 2022 | ₹20.00 Cr | Open |
Yes Bank Limited Creation Date: 14 Jul 2015 | ₹6.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 23 Jan 2015 | ₹8.20 Cr | Satisfied |
How Many Employees Work at Vipul Life Science?
Unlock and access historical data on people associated with Vipul Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vipul Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipul Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
